BANK OF AMERICA CORP /DE/ Income Taxes Disclosure
| Income Before Income Tax Expense | |||||||||||||||||
| December 31 | |||||||||||||||||
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||
| U.S. | $ | 28,813 | $ | 24,251 | $ | 23,978 | |||||||||||
Non-U.S. (1) | 8,882 | 8,972 | 8,552 | ||||||||||||||
| Income before income tax expense | $ | 37,695 | $ | 33,223 | $ | 32,530 | |||||||||||
| Income Tax Expense | |||||||||||||||||
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||
| Current income tax expense | |||||||||||||||||
| U.S. federal | $ | 4,202 | $ | 4,709 | $ | 4,760 | |||||||||||
| U.S. state and local | 442 | 603 | 559 | ||||||||||||||
| Non-U.S. | 2,247 | 2,065 | 1,918 | ||||||||||||||
| Total current expense | 6,891 | 7,377 | 7,237 | ||||||||||||||
Deferred income tax expense (benefit) | |||||||||||||||||
| U.S. federal | (114) | (1,679) | (1,233) | ||||||||||||||
| U.S. state and local | 239 | 153 | (62) | ||||||||||||||
| Non-U.S. | 170 | 399 | 283 | ||||||||||||||
Total deferred expense (benefit) | 295 | (1,127) | (1,012) | ||||||||||||||
| Total income tax expense | $ | 7,186 | $ | 6,250 | $ | 6,225 | |||||||||||
| Reconciliation of Income Tax Expense | |||||||||||||||||||||||||||||||||||
| Amount | Percent | Amount | Percent | Amount | Percent | ||||||||||||||||||||||||||||||
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| Expected U.S. federal income tax expense | $ | 7,916 | 21.0 | % | $ | 6,976 | 21.0 | % | $ | 6,831 | 21.0 | % | |||||||||||||||||||||||
| Increase (decrease) in taxes resulting from: | |||||||||||||||||||||||||||||||||||
| State and local income tax, net of federal income tax deduction | 726 | 2.0 | 690 | 2.1 | 331 | 1.0 | |||||||||||||||||||||||||||||
| Tax credits | |||||||||||||||||||||||||||||||||||
| PTCs and LIHTCs accounted for under PAM | (633) | (1.7) | (587) | (1.8) | (600) | (1.8) | |||||||||||||||||||||||||||||
| ITCs and other PTCs | (705) | (1.9) | (924) | (2.8) | (568) | (1.7) | |||||||||||||||||||||||||||||
| Other | (216) | (0.6) | (307) | (0.9) | (227) | (0.7) | |||||||||||||||||||||||||||||
| Nontaxable or nondeductible items | |||||||||||||||||||||||||||||||||||
| Tax-exempt income, including dividends | (405) | (1.1) | (477) | (1.4) | (411) | (1.3) | |||||||||||||||||||||||||||||
| Nondeductible expenses | 419 | 1.1 | 426 | 1.2 | 405 | 1.2 | |||||||||||||||||||||||||||||
| Other | (215) | (0.6) | (15) | — | (24) | (0.1) | |||||||||||||||||||||||||||||
| Changes in unrecognized tax benefits | (187) | (0.5) | (99) | (0.3) | (26) | (0.1) | |||||||||||||||||||||||||||||
| Foreign tax effects | 550 | 1.5 | 586 | 1.7 | 381 | 1.2 | |||||||||||||||||||||||||||||
| Effect of cross-border tax laws | (205) | (0.5) | (175) | (0.5) | (83) | (0.3) | |||||||||||||||||||||||||||||
| Changes in valuation allowances | 149 | 0.4 | 224 | 0.7 | 303 | 0.9 | |||||||||||||||||||||||||||||
| Other | (8) | — | (68) | (0.2) | (87) | (0.2) | |||||||||||||||||||||||||||||
| Total income tax expense (benefit) | $ | 7,186 | 19.1 | % | $ | 6,250 | 18.8 | % | $ | 6,225 | 19.1 | % | |||||||||||||||||||||||
| Reconciliation of the Change in Unrecognized Tax Benefits | |||||||||||||||||
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||
| Balance, January 1 | $ | 684 | $ | 811 | $ | 1,056 | |||||||||||
Increases related to positions taken during the current year | 54 | 55 | 76 | ||||||||||||||
Increases related to positions taken during prior years (1) | 24 | 39 | 139 | ||||||||||||||
Decreases related to positions taken during prior years (1) | (214) | (134) | (32) | ||||||||||||||
| Settlements | (46) | (62) | (380) | ||||||||||||||
| Expiration of statute of limitations | (19) | (25) | (48) | ||||||||||||||
| Balance, December 31 | $ | 483 | $ | 684 | $ | 811 | |||||||||||
| Tax Examination Status | |||||||||||
Years under Examination (1) | Status at December 31, 2025 | ||||||||||
| United States | 2017-2023 | Field Examination | |||||||||
| California | 2018-2021 | Field Examination | |||||||||
| New York | 2022-2024 | Field Examination | |||||||||
| New York City | 2022-2024 | To begin in 2026 | |||||||||
United Kingdom (2) | 2021-2023 | Field Examination | |||||||||
| Deferred Tax Assets and Liabilities | |||||||||||
| December 31 | |||||||||||
| (Dollars in millions) | 2025 | 2024 | |||||||||
| Deferred tax assets | |||||||||||
| Tax attribute carryforwards | $ | 12,875 | 11,898 | ||||||||
| Allowance for credit losses | 3,415 | 3,463 | |||||||||
| Lease liability | 2,025 | 2,169 | |||||||||
| Employee compensation and retirement benefits | 1,807 | 1,760 | |||||||||
| Accrued expenses | 1,030 | 1,379 | |||||||||
| Security, loan and debt valuations | 559 | 2,680 | |||||||||
| Other | 2,469 | 2,339 | |||||||||
| Gross deferred tax assets | 24,180 | 25,688 | |||||||||
| Valuation allowance | (2,310) | (2,361) | |||||||||
| Total deferred tax assets, net of valuation allowance | 21,870 | 23,327 | |||||||||
| Deferred tax liabilities | |||||||||||
| Equipment lease financing | 3,246 | 3,021 | |||||||||
| Right-of-use asset | 1,873 | 2,025 | |||||||||
| Other | 1,747 | 1,920 | |||||||||
| Gross deferred tax liabilities | 6,866 | 6,966 | |||||||||
| Net deferred tax assets | $ | 15,004 | 16,361 | ||||||||
| Net Operating Loss and Tax Credit Carryforward Deferred Tax Assets | |||||||||||||||||||||||
| (Dollars in millions) | Deferred Tax Asset | Valuation Allowance | Net Deferred Tax Asset | First Year Expiring | |||||||||||||||||||
Net operating losses - U.K. (1) | $ | 7,447 | $ | — | $ | 7,447 | None | ||||||||||||||||
Net operating losses - other non-U.S. | 67 | (25) | 42 | Various | |||||||||||||||||||
Net operating losses - U.S. states (2) | 389 | (242) | 147 | Various | |||||||||||||||||||
| General business credits | 3,920 | — | 3,920 | After 2045 | |||||||||||||||||||
| Foreign tax credits | 1,052 | (1,052) | — | After 2028 | |||||||||||||||||||
| Income Taxes Paid | |||||||||||||||||
| (Dollars in millions) | 2025 | 2024 | 2023 | ||||||||||||||
Taxes paid by jurisdiction | |||||||||||||||||
U.S. federal | $ | 1,050 | $ | 1,143 | $ | 775 | |||||||||||
U.S. state and local | |||||||||||||||||
California (1) | not required | not required | 230 | ||||||||||||||
| Other | 651 | 569 | 525 | ||||||||||||||
Total U.S. state and local | 651 | 569 | 755 | ||||||||||||||
| Non-U.S. | |||||||||||||||||
| United Kingdom | 433 | 578 | 519 | ||||||||||||||
| India | 272 | 292 | 266 | ||||||||||||||
| Other | 1,524 | 1,240 | 1,090 | ||||||||||||||
Total Non-U.S. | 2,229 | 2,110 | 1,875 | ||||||||||||||
Total income taxes paid | $ | 3,930 | $ | 3,822 | $ | 3,405 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 25, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 20, 2024 | |
| 2022 | Feb 22, 2023 | |
| 2021 | Feb 22, 2022 | |
| 2020 | Feb 24, 2021 | |
| 2019 | Feb 19, 2020 | |
| 2018 | Feb 26, 2019 | |
| 2017 | Feb 22, 2018 | |
| 2016 | Feb 23, 2017 | |
| 2015 | Feb 24, 2016 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.